Sublocade Medication Assisted Treatment
Opioid addiction not only affects the individual but also their loved ones, making recovery a significant challenge. Beginning the journey to recovery requires immense courage.
At CMAR, our Sublocade treatment program is designed to assist those struggling with opioid dependence.
Sublocade, an extended-release injection of buprenorphine, consistently and effectively manages withdrawal symptoms and cravings. Through a personalized approach, we empower individuals to achieve lasting recovery.
At CMAR, we are committed to delivering comprehensive care and support to help you reclaim your life.
What is Sublocade
- FDA-approved injectable
- Blocks euphoric effects
- Personalized treatment plans
Benefits of Sublocade Treatment
![](https://www.colorado-recovery.com/wp-content/uploads/2024/06/sublocade-img.webp)
Prevention of Relapse
- By providing continuous medication delivery, Sublocade significantly reduces the likelihood of relapse, helping individuals maintain their sobriety.
Reduction in Cravings
- Sublocade helps manage cravings, allowing patients to focus on their recovery without the constant urge to use opioids.
Convenient Administration
- As a once-monthly injection, Sublocade offers a convenient and discreet treatment option, eliminating the need for daily medication adherence.
Supportive of Long-term Recovery
- Sublocade is most effective when combined with comprehensive therapy and support programs, promoting sustained recovery and overall well-being.
HOW Sublocade WORKS
Sublocade works by utilizing buprenorphine, a partial opioid agonist, to manage opioid dependence. Buprenorphine binds to opioid receptors in the brain, alleviating withdrawal symptoms and reducing cravings without producing the intense euphoria associated with other opioids.
This extended-release formulation provides continuous medication delivery over a month, ensuring consistent support for individuals in their recovery journey. The once-monthly injection simplifies the treatment regimen, helping to maintain stability and reduce the risk of relapse. This approach allows patients to focus on their recovery with fewer interruptions.
- Mechanism of Action: Sublocade contains buprenorphine, which binds to opioid receptors in the brain, reducing withdrawal symptoms and cravings without causing significant euphoria.
- Administration Frequency: Sublocade is administered once a month as an extended-release injection.
- Eligibility: Patients must undergo a thorough medical evaluation to determine their suitability for Sublocade treatment.
- Support: Comprehensive support services, including regular check-ins and personalized care plans, are provided to ensure the best possible outcomes and support long-term sobriety.
Sublocade Evidence of Effectiveness
Suboxone, which includes buprenorphine and naloxone, is highly effective in treating opioid use disorder by reducing cravings and withdrawal symptoms. Buprenorphine acts as a partial opioid agonist, minimizing the risk of overdose, while naloxone prevents misuse, enhancing safety.
Improved Retention Rates
In a phase 3 clinical trial, Sublocade demonstrated superior retention rates compared to placebo. Patients receiving Sublocade had significantly higher treatment retention rates, with over 80% opioid-free weeks achieved by 28.4% of those on a 300 mg/100 mg regimen and 29.1% of those on a 300 mg/300 mg regimen, compared to only 2% in the placebo group
High Efficacy in Reducing Illicit Opioid Use
The same study showed that Sublocade was highly effective in reducing illicit opioid use. Weekly urine drug screens and self-reports confirmed a higher percentage of opioid-negative samples among Sublocade recipients than those on placebo.
Patient Satisfaction and Life Improvements
Participants reported high satisfaction with Sublocade and noted significant improvements in overall quality of life. The once-monthly injection schedule reduces the burden of daily medication, making adherence easier and supporting sustained recovery.
Who Are the Best Candidates for Sublocade?
Sublocade is most effective for individuals who meet specific eligibility criteria to ensure the best outcomes:
Patients diagnosed with opioid use disorder, particularly those who have struggled with other treatments.
Individuals must be stabilized on a daily dose of buprenorphine for at least seven days before starting Sublocade.
Candidates should be healthy enough to take the prescribed medication and commit to regular check-ups.
A comprehensive medical assessment is carried out to evaluate suitability, taking into account factors such as the patient’s overall health, history of substance use, and any co-occurring mental health conditions.
The most suitable candidates are those dedicated to a comprehensive recovery program, including therapy and support groups, as these complement the medication’s effectiveness. Our team is committed to working closely with each patient to create a personalized treatment plan that meets their unique needs.
Potential Side Effects
While Sublocade is effective in treating opioid dependence, it may cause side effects in some patients.
Common side effects include:
- Constipation
- Nausea
- Vomiting
- Headache
- Injection site reactions
- Allergic reactions
- Respiratory issues
Patients should promptly inform their healthcare provider of any adverse effects they experience. Regular monitoring and open communication with the medical team help manage and mitigate these side effects, ensuring the safety and well-being of each patient.
HOW IT WORKS
1
Verify Insurance
We'll check your insurance coverage
2
Complete a personalized assessment
Answer a few quetions and tell us your story
3
Start Treatment
Your healing journey and new life starts now
Seeking help for a loved one?
There’s hope for a better, drug and alcohol-free life. If you or a loved one is seeking help for an opioid, benzo, or alcohol addiction, CMAR can provide the support and resources needed to get you on the path to recovery.
Take the First Step Toward Recovery
There is always hope for a better, drug and alcohol-free life. If you or someone you care about is struggling with opioid, benzo, or alcohol addiction, CMAR is here to offer the support and resources needed to start the journey to recovery. Our MAT program combines medication-assisted treatment with psychotherapy, case management services, and peer support for sustained recovery.
Please don’t wait to get some help. Contact us at (833) 448-0127 or online to discover more about MAT and our addiction treatment services in Denver and the surrounding areas. With the proper support, you can take control of your life.
Why Choose Colorado Medication Assisted Recovery
At CMAR, we understand that long-lasting recovery demands much more than a prescription. Recovery is a challenging personal journey of incremental change, and medication is only one element of treatment.
We know that many people suffering from substance use disorder may also have co-occurring other mental health conditions, such as depression and anxiety. We look at the family, social supports, and prior history of trauma and develop individual treatment plans accordingly. We believe treating mental health alongside addiction is an indispensable part of our opioid addiction treatment programs and alcohol addiction treatment programs.
We help our patients identify the causes of anger, fear, sadness, and loneliness and provide tools to cope effectively so they don’t cause a relapse.
Talk to Someone
Our addiction specialists are here to help 24/7. Give us a call and we can help find the right treatment program for you or your loved one – even if it’s not ours! We are here to help.
![](https://www.colorado-recovery.com/wp-content/uploads/2024/04/Contact-Addiction-Recovery-Therapist-Background2-1.webp)